Carsten Skurk
Latest contributions
Broadening OPTIONs for LAA closure: innovations and outcomes
20 May 2025 – From EuroPCR 2025
Explore the latest insights into LAA closure from EuroPCR 2025. This session highlights results from the OPTION trial—the largest RCT comparing LAAC (with Watchman FLX) to DOAC therapy in AF patients undergoing ablation. The findings? Comparable stroke prevention at 3 years, with a 56 % reduction...
High-risk PCI in cardiogenic shock and calcified vessels
16 May 2023 – From EuroPCR 2023
Looking for a better insight into this session devoted to high-risk PCI in cardiogenic shock and calcified vessels? Revisit the slides presented and review the detailed results of a series of important studies conducted on the subject.
